Could a new injection tame atrial fibrillation?

NCT ID NCT06280768

Completed Disease control Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd Source: ClinicalTrials.gov ↗

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This early-stage trial is testing an investigational drug called SHR-2004, given as multiple injections under the skin, in about 10 adults with atrial fibrillation (an irregular heartbeat). The main goal is to see if the drug is safe and tolerable, and to learn how it moves through the body. Researchers will also look at how it affects blood clotting and whether it triggers an immune response.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SHR-2004 injection
What this could lead to: If safe and effective, SHR-2004 could offer a new way to manage atrial fibrillation and reduce stroke risk.
What could go wrong: This is an early, small trial focused on safety, not effectiveness. The drug may not work or could cause bleeding or other side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation atrial flutter

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION

Contacts and locations

Locations

The second Affiliated Hospital Zhejiang University School of Mdeicine

Hangzhou, Zhejiang, 310009, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.